Provided by Tiger Trade Technology Pte. Ltd.

Merck

144.71
-2.8200-1.91%
Pre-market: 145.580.8700+0.60%08:21 EDT
Volume:7.54M
Turnover:1.09B
Market Cap:357.02B
PE:113.69
High:148.00
Open:147.94
Low:144.10
Close:147.53
52wk High:156.92
52wk Low:77.58
Shares:2.47B
Float Shares:2.47B
Volume Ratio:0.95
T/O Rate:0.31%
Dividend:3.36
Dividend Rate:2.32%
EPS(TTM):1.27
EPS(LYR):7.28
ROE:6.96%
ROA:11.87%
PB:8.51
PE(LYR):19.88

Loading ...

Press Release: Merck Announces Fourth-Quarter 2026 Dividend

Dow Jones
·
Jul 29

MerckRapidly Advances ADC+IO 2.0 Strategy with SKB BIO's TROP2 ADC Joint PD-1/VEGF Bispecific Antibody Phase II Trial

Deep News
·
Jul 29

US Lawmakers Press Health Secretary Robert F. Kennedy Jr. on Vaccine Settlement

Reuters
·
Jul 29

Merck price target raised to $150 from $140 at Barclays

TIPRANKS
·
Jul 29

Earning Preview: Merck Q2 revenue expected to increase by 2.98%, and institutional views are mostly bullish

Earnings Agent
·
Jul 29

Xetra Closing Stock Prices

Dow Jones
·
Jul 29

Movement Alert|Merck Rises 3.12% in Regular Trading, Pharma Sector Rally and Barclays Target Price Upgrade

Market Focus
·
Jul 28

Merck & Co. on Track for Record High Close

Dow Jones
·
Jul 28

Merck KGaA (0O14) Receives a Hold from Jefferies

TIPRANKS
·
Jul 28

Barclays Adjusts Merck & Co. Price Target to $150 From $140, Maintains Overweight Rating

MT Newswires Live
·
Jul 28

Merck & Co Inc : Bernstein Raises Target Price to $105 from $100

THOMSON REUTERS
·
Jul 27

Will Merck’s (MRK) Early Royalty-Free HIV PrEP Licensing Strategy Redefine Its Global Health Narrative

Simply Wall St.
·
Jul 26

Is Merck (MRK) A Bargain After FDA Approval For LIPFENDRA And HIV PrEP Expansion?

Simply Wall St.
·
Jul 25

Merck Launches Early Access Initiative for Monthly Oral HIV Prevention Drug Alimatravir

Deep News
·
Jul 24

Aspen Pharmacare: Under Agreement, Co to Receive Technical Package from Msd, Together with Licensing Rights Covering 129 Countries

THOMSON REUTERS
·
Jul 24

Merck Outlines Access Plan for Investigational Monthly HIV Prevention Pill

MT Newswires Live
·
Jul 24

Gilead Sciences Says EMA Recommends Trodelvy-Keytruda Combination for Breast Cancer

MT Newswires Live
·
Jul 24

Merck announces initial access plans for alimatravir

TIPRANKS
·
Jul 24

Merck & Co - Signs Seven Voluntary Licensing Agreements with Generic Manufacturers in Africa and India

THOMSON REUTERS
·
Jul 24

Merck & Co - Royalty-free Agreements Enable Supply of Generic Alimatravir in 129 Lmics

THOMSON REUTERS
·
Jul 24